Literature DB >> 29630099

Upregulation of miR-132 attenuates osteoblast differentiation of UC-MSCs.

Z-L Xue1, Y-L Meng, J-H Ge.   

Abstract

OBJECTIVE: Wnt/β-catenin signaling pathway plays a role in upregulating expression of osteoblast (OB) specific transcriptional factor Osterix and promoting OB differentiation. It was shown that the elevation of the miR-132 level was associated with sclerotizing inhibition. Bioinformatics analysis revealed the complementary binding site between miR-132 and 3'-UTR of β-catenin. This study investigated the influence of miR-214 in regulating β-catenin expression and differentiation of umbilical cord mesenchymal stem cells (UC-MSCs) into OB.
MATERIALS AND METHODS: UC-MSCs were induced to differentiate to OB. The expressions of miR-132, β-catenin, Osterix, and ALP, together with ALP activity were detected on day 0, 5, 10, and 15. The regulatory relationship between miR-132 and β-catenin was confirmed by dual luciferase reporter gene assay. UC-MSCs were divided into five groups, including agomir-control, miR-132 agomir, pGPH1-NC, pGPH1-β-catenin, and miR-132 agomir + pGPH1-β-catenin groups. β-catenin, Osterix, and ALP expressions, together with ALP activity were tested after induction for 15 days.
RESULTS: MiR-132 was downregulated, while β-catenin Osterix and ALP expressions, together with ALP activity were enhanced in the process of UC-MSCs differentiating into OBs. MiR-132 agomir and/or pGPH1-β-catenin transfection significantly reduced β-catenin expression, downregulated Wnt/β-catenin signaling pathway activity, declined Osterix level, weakened ALP expression and activity, and attenuated OB differentiation of UC-MSCs.
CONCLUSIONS: The level of β-catenin was enhanced, while the miR-132 level was decreased in the process of UC-MSCs differentiating into OBs. Upregulation of miR-132 inhibited the differentiation of UC-MSCs through suppressing β-catenin expression, attenuating Wnt/β-catenin signaling pathway activity, and downregulating Osterix level.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29630099     DOI: 10.26355/eurrev_201803_14562

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

Review 1.  The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies.

Authors:  Maria Rosa Iaquinta; Carmen Lanzillotti; Chiara Mazziotta; Ilaria Bononi; Francesca Frontini; Elisa Mazzoni; Lucia Oton-Gonzalez; John Charles Rotondo; Elena Torreggiani; Mauro Tognon; Fernanda Martini
Journal:  Theranostics       Date:  2021-04-30       Impact factor: 11.556

Review 2.  MicroRNAs Modulate Signaling Pathways in Osteogenic Differentiation of Mesenchymal Stem Cells.

Authors:  Chiara Mazziotta; Carmen Lanzillotti; Maria Rosa Iaquinta; Francesca Taraballi; Elena Torreggiani; John Charles Rotondo; Lucia Otòn-Gonzalez; Elisa Mazzoni; Francesca Frontini; Ilaria Bononi; Monica De Mattei; Mauro Tognon; Fernanda Martini
Journal:  Int J Mol Sci       Date:  2021-02-27       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.